Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)

Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)

Objective: To compare the differences in adverse effects and efficacy profile between bacillus Calmette-Guerin (BCG) Danish 1331 and BCG Moscow-I strain in management of non-muscle invasive bladder cancer. Methods: Clinical data of 188 cases of non-muscle invasive bladder cancer treated with BCG bet...

Full description

Bibliographic Details
Main Authors: Yuvaraja B. Thyavihally, Preetham Dev, Santosh Waigankar, Abhinav Pednekar, Nevitha Athikari, Abhijit Raut, Archan Khandekar, Naresh Badlani, Ashishkumar Asari
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Asian Journal of Urology
Subjects:
Adjuvant bacillus Calmette-Guerin
Bacillus Calmette-Guerin adverse effects
Danish 1331 strain
Intravesical therapy
Moscow-I strain
Non-muscle invasive bladder cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388221000394

Internet

http://www.sciencedirect.com/science/article/pii/S2214388221000394

Similar Items